Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
The emergence of immunotherapy has been an astounding breakthrough in cancer treatments.In particular, immune checkpoint inhibitors, targeting PD-1 and CTLA-4, have shown remarkable therapeutic outcomes.However, response rates from immunotherapy have been reported to be varied, with some having pronounced success and others with minimal to no clini